Rubén Alvarez‐Sánchez

978 total citations
24 papers, 728 citations indexed

About

Rubén Alvarez‐Sánchez is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Rubén Alvarez‐Sánchez has authored 24 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Ophthalmology. Recurrent topics in Rubén Alvarez‐Sánchez's work include Drug Transport and Resistance Mechanisms (7 papers), melanin and skin pigmentation (3 papers) and Retinal Diseases and Treatments (3 papers). Rubén Alvarez‐Sánchez is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), melanin and skin pigmentation (3 papers) and Retinal Diseases and Treatments (3 papers). Rubén Alvarez‐Sánchez collaborates with scholars based in Switzerland, Germany and Finland. Rubén Alvarez‐Sánchez's co-authors include Camilla Pease, David A. Basketter, Axel Pähler, Arto Urtti, Thomas Härtung, Jean‐Pierre Lepoittevin, Franz Schuler, Sara Belli, Wolfgang Völkel and Antonello Caruso and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Rubén Alvarez‐Sánchez

24 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rubén Alvarez‐Sánchez Switzerland 15 294 120 104 94 88 24 728
P.M. Woollard United Kingdom 19 403 1.4× 177 1.5× 114 1.1× 276 2.9× 17 0.2× 25 1.2k
Gustav Graff United States 20 369 1.3× 23 0.2× 34 0.3× 80 0.9× 174 2.0× 35 1.0k
Edmond C. Ku Switzerland 13 196 0.7× 15 0.1× 32 0.3× 68 0.7× 47 0.5× 18 722
P. Gautheron France 14 316 1.1× 12 0.1× 21 0.2× 190 2.0× 89 1.0× 32 891
Giorgio Ottaviani Switzerland 14 189 0.6× 46 0.4× 73 0.7× 144 1.5× 15 0.2× 22 635
Narayanan Surendran United States 12 146 0.5× 8 0.1× 107 1.0× 54 0.6× 15 0.2× 22 462
Julián Garcı́a-Rafanell Spain 20 295 1.0× 32 0.3× 43 0.4× 680 7.2× 12 0.1× 42 1.3k
Giichi Goto Japan 19 543 1.8× 53 0.4× 79 0.8× 611 6.5× 19 0.2× 59 2.0k
Keizo Ito Japan 15 297 1.0× 8 0.1× 47 0.5× 199 2.1× 20 0.2× 72 821

Countries citing papers authored by Rubén Alvarez‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Rubén Alvarez‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubén Alvarez‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubén Alvarez‐Sánchez more than expected).

Fields of papers citing papers by Rubén Alvarez‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rubén Alvarez‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubén Alvarez‐Sánchez. The network helps show where Rubén Alvarez‐Sánchez may publish in the future.

Co-authorship network of co-authors of Rubén Alvarez‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Rubén Alvarez‐Sánchez. A scholar is included among the top collaborators of Rubén Alvarez‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rubén Alvarez‐Sánchez. Rubén Alvarez‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarez‐Sánchez, Rubén, et al.. (2024). Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin in Rabbits Shows Potential of Topical Eye Drops for Posterior Segment Treatment. Investigative Ophthalmology & Visual Science. 65(12). 14–14. 3 indexed citations
2.
Alvarez‐Sánchez, Rubén, et al.. (2021). Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats. Molecular Pharmaceutics. 18(6). 2208–2217. 14 indexed citations
3.
Hauri, Simon, et al.. (2020). Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics. 12(9). 810–810. 6 indexed citations
4.
Cantrill, Carina, et al.. (2019). Establishment of an In Vitro–In Vivo Correlation for Melanin Binding and the Extension of the Ocular Half-Life of Small-Molecule Drugs. Molecular Pharmaceutics. 16(12). 4890–4901. 29 indexed citations
5.
Thun, Jürgen, et al.. (2019). Influence of Melanin Characteristics on Drug Binding Properties. Molecular Pharmaceutics. 16(6). 2549–2556. 28 indexed citations
6.
Reutlinger, Michael, et al.. (2018). Understanding Molecular Drivers of Melanin Binding To Support Rational Design of Small Molecule Ophthalmic Drugs. Journal of Medicinal Chemistry. 61(22). 10106–10115. 27 indexed citations
7.
Neuhaus, Claudia S., Björn Wagner, Hélène E. Aschmann, et al.. (2017). Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability. European Journal of Pharmaceutical Sciences. 104. 150–161. 20 indexed citations
8.
Schuler, Franz, et al.. (2016). Extension of the dissolution-precipitation model for kinetic elucidation of solvent-mediated polymorphic transformations. European Journal of Pharmaceutics and Biopharmaceutics. 109. 43–48. 11 indexed citations
9.
Raab, S., Haiyan Wang, Sabine Uhles, et al.. (2015). Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Molecular Metabolism. 5(1). 47–56. 78 indexed citations
10.
Wagner, Björn, et al.. (2015). Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption. Molecular Pharmaceutics. 13(2). 586–598. 42 indexed citations
11.
Ottaviani, Giorgio, et al.. (2015). Importance of Critical Micellar Concentration for the Prediction of Solubility Enhancement in Biorelevant Media. Molecular Pharmaceutics. 12(4). 1171–1179. 23 indexed citations
12.
Pinard, Emmanuel, Daniela Alberati, Rubén Alvarez‐Sánchez, et al.. (2014). 3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors. ACS Medicinal Chemistry Letters. 5(4). 428–433. 5 indexed citations
13.
Caruso, Antonello, Rubén Alvarez‐Sánchez, Alexander Hillebrecht, et al.. (2013). PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation. Biochemical Pharmacology. 85(11). 1684–1699. 24 indexed citations
14.
Martin, Rainer E., Caterina Bissantz, Henrietta Dehmlow, et al.. (2012). 2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5). ChemMedChem. 8(4). 569–576. 35 indexed citations
15.
Hebeisen, Paul, Wolfgang Haap, Bernd Kuhn, et al.. (2011). Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3237–3242. 14 indexed citations
16.
Martin, Rainer E., Peter J. Mohr, Hans Peter Maerki, et al.. (2009). Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6106–6113. 14 indexed citations
17.
18.
Völkel, Wolfgang, et al.. (2005). Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. Free Radical Biology and Medicine. 38(11). 1526–1536. 67 indexed citations
19.
20.
Alvarez‐Sánchez, Rubén, et al.. (2003). Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione. Bioorganic & Medicinal Chemistry Letters. 14(2). 365–368. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.M. Woollard Breakdown of academic impact, for papers by Gustav Graff Breakdown of academic impact, for papers by Edmond C. Ku Breakdown of academic impact, for papers by P. Gautheron Breakdown of academic impact, for papers by Giorgio Ottaviani Breakdown of academic impact, for papers by Narayanan Surendran Breakdown of academic impact, for papers by Julián Garcı́a-Rafanell Breakdown of academic impact, for papers by Giichi Goto Breakdown of academic impact, for papers by Keizo Ito
Rankless by CCL
2026